流行性感冒具有季節性和高傳染性，由流感病毒引起，主要包括甲型流感（A）和乙型流感（B）。世界范圍內，每年約有5%-15%的人群感染流感病毒，并且已導致多次致命的大流行，包括1918年西班牙流感(H1N1)、亞洲流感(H2N2)、香港流感(H3N2)，以及2009年H1N1爆發，造成了數百萬人的生命損失。
目前，接種疫苗被認為是預防流感的有效措施。但是由于流感病毒的高頻率抗原漂移或轉移，經常會造成抗體逃逸，因此，能夠結合多種病毒亞型，并能夠彌補病毒高突變率的廣譜抗體就具有重要的價值。
義翹神州結合多年抗體開發及病毒研究，已研制成功多種抗流感病毒的廣譜抗體，并將其命名為泛流感抗體，以幫助流感病毒的生物及治療研究。
抗HA廣譜抗體
HA具有獨特作用，廣泛用于抗流感抗體的研究。通過WB和ELISA對HA抗原進行識別。結果表明，兔單抗86001-RM01和11053-R004分別是甲型和乙型流感的廣譜抗體。
| Number | Antigens | ELISA Assay | WB Assay | ELISA Assay | WB Assay | Antigen Subtype | Antigen Strain | Vaccine Strain |
| 86001-RM01 | 11053-R004 | |||||||
| 1 | 40719-V08H | +++ | +++ | - | - | H1N1 | A/Brisbane/02/2018 | 2019-2020 |
| 2 | 11055-V08H | +++ | +++ | - | - | A/California/04/2009 | - | |
| 3 | 11085-V08B | +++ | +++ | - | - | A/California/07/2009 | 2016-2017, 2015-2016 | |
| 4 | 40717-V08H | +++ | +++ | - | - | A/Guangdong-Maonan/SWL1536/2019 | 2020-2021 | |
| 5 | 40567-V08H1 | +++ | +++ | - | - | A/Michigan/45/2015 | 2018-2019, 2017-2018 | |
| 6 | 11684-V08H | +++ | +++ | - | - | A/Puerto Rico/8/1934 | - | |
| 7 | 40787-V08H | +++ | +++ | - | - | (A/Wisconsin/588/2019) / (A/Victoria/2570/2019) | 2021-2022 | |
| 8 | 11056-V08H | +++ | +++ | - | - | H3N2 | A/Brisbane/10/2007 | - |
| 9 | 40789-V08H | +++ | +++ | - | - | A/Cambodia/e0826360/2020 | 2021-2022 | |
| 10 | 40721-V08H | +++ | +++ | + | - | A/Hong Kong/2671/2019 | 2020-2021 | |
| 11 | 40765-V08H | +++ | +++ | - | - | A/Hong Kong/45/2019 | 2020-2021 | |
| 12 | 40555-V08B | +++ | +++ | - | - | A/Hong Kong/4801/2014 | 2017-2018, 2016-2017 | |
| 13 | 40720-V08H | +++ | +++ | - | - | A/Kansas/14/2017 | 2019-2020 | |
| 14 | 40580-V08H | +++ | +++ | - | - | A/Singapore/INFIMH-16-0019/2016 | 2018-2019 | |
| 15 | 40497-V08B | +++ | +++ | - | - | A/Switzerland/9715293/2013 | 2015-2016 | |
| 16 | 40016-V08B | - | - | +++ | +++ | Influenza B | B/Brisbane/60/2008 | 2017-2018, 2016-2017, 2015-2016 |
| 17 | 40581-V08H | - | - | +++ | +++ | B/Colorado/06/2017 | 2019-2020, 2018-2019 | |
| 18 | 11053-V08H | - | - | +++ | +++ | B/Florida/4/2006 | - | |
| 19 | 40498-V08B | - | - | +++ | +++ | B/PHUKET/3073/2013 | 2021-2022, 2020-2021, 2019-2020, 2018-2019, 2017-2018, 2016-2017, 2015-2016 | |
| 20 | 40722-V08H | - | - | +++ | +++ | |||
| B/Washington/02/2019 | 2021-2022, 2020-2021 | |||||||
-: No Effect; +: Medium/Minimal Effect; +++: Strong Effect
抗NP廣譜抗體
通過WB和ELISA對NP抗原進行識別，共發現16個甲型或乙型流感廣譜抗體。
| Ab Cat# | Antigen | Type | Ig Type | Application | |
| Pan Influenza A Nucleoprotein Antibody | 40208-MM03 | Influenza A H3N2 NP | Mouse MAb | Mouse IgG1 | WB, ELISA |
| 40208-MM04 | Influenza A H3N2 NP | Mouse MAb | Mouse IgG1 | WB, ELISA | |
| 40208-R010 | Influenza A H3N2 NP | Rabbit MAb | Rabbit IgG | WB, ELISA | |
| 40208-R061 | Influenza A H3N2 NP | Rabbit MAb | Rabbit IgG | WB, ELISA | |
| 40208-R113 | Influenza A H3N2 NP | Rabbit MAb | Rabbit IgG | WB, ELISA | |
| 40208-R014 | Influenza A H3N2 NP | Rabbit MAb | Rabbit IgG | ELISA(Det) | |
| 40208-R117 | Influenza A H3N2 NP | Rabbit MAb | Rabbit IgG | ELISA(Cap) | |
| 40205-MM16 | Influenza A H1N1 NP | Mouse MAb | Mouse IgG2a | WB, ELISA(Cap) | |
| 40205-MM18 | Influenza A H1N1 NP | Mouse MAb | Mouse IgG2b | WB, ELISA(Det) | |
| 40205-R063 | Influenza A H1N1 NP | Rabbit MAb | Rabbit IgG | ELISA, ELISA(Cap) | |
| Pan Influenza B Nucleoprotein Antibody | 40438-MM05 | Influenza B NP | Mouse MAb | Mouse IgG1 | WB, ELISA (Cap) |
| 40438-MM09 | Influenza B NP | Mouse MAb | Mouse IgG1 | WB, ELISA | |
| 40438-R004 | Influenza B NP | Rabbit MAb | Rabbit IgG | WB, ELISA (Cap) | |
| 40438-R016 | Influenza B NP | Rabbit MAb | Rabbit IgG | WB, ELISA | |
| 40438-R036 | Influenza B NP | Rabbit MAb | Rabbit IgG | WB, ELISA (Cap), ELISA (Det) | |
| 40438-MM10 | Influenza B NP | Mouse MAb | Mouse IgG1 | WB, ELISA(Det) |
